Physician profile
William E Umphlett
NPI 1669824280
$3,042.32
in general payments reported to CMS, 2019-2025
9 companies · $358 in 2025
The $358 reported for 2025 was more than what 86% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.87 · 2020: $237 · 2021: $23.85 · 2022: $477 · 2023: $517 · 2024: $1,348 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.24 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,406.13 | 2022-2025 | |
| Ultradent Products INC | $227.69 | 2020 | |
| Dentsply LLC | $200.00 | 2024 | |
| Dentsply Sirona INC | $69.68 | 2019 | |
| Voco America INC. | $59.08 | 2019-2024 | Futurabond U, Meron Plus Qm, Rebilda Dc |
| Zimmer Biomet Holdings, INC. | $23.85 | 2021 | |
| Solventum Corporation | $23.71 | 2024 | 3m Scotchbond, 3m Filtek, Filtek |
| Envista Holdings Corporation | $17.88 | 2024 | Tf Adaptive |
| Colgate Oral Pharmaceuticals, INC. | $14.30 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Umphlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.